Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) Q425

<p class='reportable-dateline'><strong>Dallas, Tx -- April 1, 2026</strong></p><p class='reportable-excerpt'>DALLAS, TX -- April 1st, 2025 -- Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition exited FY25 with ZUNVEYL showing increasingly durable traction in long-term care, as 4Q25 net product revenue reached $2.5M and FY25 total revenue reached $10.2M, including $6.8M of ZUNVEYL sales. More importantly, demand indicators continued to inflect, with bottles dispensed rising 62% q/q to 4,941 with December alone reaching a record 1,859 bottle. Repeat ordering remained strong, supporting management’s view that ZUNVEYL is moving beyond early trial use and becoming more embedded in facility treatment protocols.</p><p>To view the full announcement, including downloadable images, bios, and more, <a href='https://stonegateinc.reportablenews.com/pr/stonegate-capital-partners-updates-coverage-on-alpha-cognition-inc-nasdaq-acog-q425' class='reportable-link'>click here</a>.</p><div class='reportable-key-takeaways'><h3>Key Takeaways:</h3><ul><li>ZUNVEYL adoption is becoming durable. 4Q25 sales hit $2.5M, bottles dispensed rose 62% q/q to 4,941, and December reached 1,859.</li><li>LTC traction is strengthening with repeat behavior. 729 ordering homes, 82% repeat orders, and 865 prescribers with 69% repeat writers support protocol adoption.</li><li>ACOG is funded to keep scaling commercialization. Ended FY25 with $66.0M cash, runway into 2027, and expects continued sequential sales growth in 2026.</li></ul></div><a href='https://stonegateinc.reportablenews.com/pr/stonegate-capital-partners-updates-coverage-on-alpha-cognition-inc-nasdaq-acog-q425'><img src='https://cdn.filestackcontent.com/GSyEy4TEQEeTg7yyBich' class='reportable-featured-image' /><p align='center'><i>Click image above to view full announcement.</i></p></a><hr class='company-boilerplate-rule' style='border: 0; border-top: 1px solid rgba(0,0,0,0.1);'><p class='company-boilerplate'><div><strong>About Stonegate<br></strong>Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.</div></p><div class='reportable-contacts'><h3>Contacts:</h3><p class='reportable-contact'>Stonegate Capital Partners<br>(214) 987-4121 <br><a href='mailto:info@stonegateinc.com'>info@stonegateinc.com</a></p></div><p>Source: <a href='https://stonegateinc.reportablenews.com/'>Stonegate, Inc.</a></p><p>Distributed by: <a href='https://reportablenews.com'>Reportable, Inc.</a></p>